Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CD9 Antikörper

CD9 Reaktivität: Maus FACS, WB, IP, IF, IHC (fro), BR Wirt: Ratte Monoclonal KMC8 unconjugated
Produktnummer ABIN1176843
  • Target Alle CD9 Antikörper anzeigen
    CD9
    Reaktivität
    • 137
    • 56
    • 29
    • 15
    • 12
    • 11
    • 10
    • 10
    • 10
    • 8
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    Maus
    Wirt
    • 85
    • 56
    • 24
    Ratte
    Klonalität
    • 120
    • 45
    Monoklonal
    Konjugat
    • 74
    • 22
    • 16
    • 15
    • 13
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Dieser CD9 Antikörper ist unkonjugiert
    Applikation
    • 118
    • 83
    • 30
    • 27
    • 27
    • 25
    • 20
    • 13
    • 12
    • 9
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Western Blotting (WB), Immunoprecipitation (IP), Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro)), Blocking Reagent (BR)
    Marke
    BD Pharmingen™
    Aufreinigung
    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
    Sterilität
    0.2 μm filtered
    Endotoxin-Niveau
    Endotoxin level is ≤ 0.01 EU/μg (≤ 0.001 ng/μg) of protein as determined by the LAL assay.
    Immunogen
    (C57BL/6 x DBA/2)F1 mouse bone marrow-derived stromal cell line BMS2
    Klon
    KMC8
    Isotyp
    IgG2a kappa
    Top Product
    Discover our top product CD9 Primärantikörper
  • Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1.0 mg/mL
    Buffer
    No azide/low endotoxin: Aqueous buffered solution containing no preservative, 0.2μm sterile filtered.
    Konservierungsmittel
    Azide free
    Lagerung
    4 °C
    Informationen zur Lagerung
    Store undiluted at 4°C. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
  • Nakorn, Miyamoto, Weissman: "Characterization of mouse clonogenic megakaryocyte progenitors." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, Issue 1, pp. 205-10, (2003) (PubMed).

    Kaji, Takeshita, Miyake, Takai, Kudo: "Functional association of CD9 with the Fc gamma receptors in macrophages." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 166, Issue 5, pp. 3256-65, (2001) (PubMed).

    Tachibana, Hemler: "Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance." in: The Journal of cell biology, Vol. 146, Issue 4, pp. 893-904, (1999) (PubMed).

    Tanio, Yamazaki, Kunisada, Miyake, Hayashi: "CD9 molecule expressed on stromal cells is involved in osteoclastogenesis." in: Experimental hematology, Vol. 27, Issue 5, pp. 853-9, (1999) (PubMed).

    Park, Yashiro, Tai, Toyo-oka, Hamaoka, Yagita, Okumura, Neben, Fujiwara: "Differential involvement of a Fas-CPP32-like protease pathway in apoptosis of TCR/CD9-costimulated, naive T cells and TCR-restimulated, activated T cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 160, Issue 12, pp. 5790-6, (1998) (PubMed).

    Pulendran, Lingappa, Kennedy, Smith, Teepe, Rudensky, Maliszewski, Maraskovsky: "Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 159, Issue 5, pp. 2222-31, (1997) (PubMed).

    Oritani, Wu, Medina, Hudson, Miyake, Gimble, Burstein, Kincade: "Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures." in: Blood, Vol. 87, Issue 6, pp. 2252-61, (1996) (PubMed).

    Wright, Tomlinson: "The ins and outs of the transmembrane 4 superfamily." in: Immunology today, Vol. 15, Issue 12, pp. 588-94, (1995) (PubMed).

    Jennings, Crossno, Fox, White, Green: "Platelet p24/CD9, a member of the tetraspanin family of proteins." in: Annals of the New York Academy of Sciences, Vol. 714, pp. 175-84, (1994) (PubMed).

    Miyake, Medina, Hayashi, Ono, Hamaoka, Kincade: "Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures." in: The Journal of experimental medicine, Vol. 171, Issue 2, pp. 477-88, (1990) (PubMed).

  • Target
    CD9
    Andere Bezeichnung
    CD9 (CD9 Produkte)
    Synonyme
    BTCC-1 antikoerper, DRAP-27 antikoerper, MIC3 antikoerper, MRP-1 antikoerper, TSPAN-29 antikoerper, TSPAN29 antikoerper, Tspan29 antikoerper, cd9 antikoerper, wu:fb61g04 antikoerper, zgc:73383 antikoerper, zgc:85743 antikoerper, CD9 molecule antikoerper, CD9 antigen antikoerper, CD9 molecule a antikoerper, CD9 antikoerper, Cd9 antikoerper, cd9a antikoerper
    Hintergrund
    The KMC8 antibody reacts with CD9, a 24-kDa member of the transmembrane 4 superfamily. In the mouse, CD9 is present on bone marrow myeloid cells, stromal cells, and megakaryocyte-committed progenitors, subsets of peripheral T and B lymphocytes, and neutrophils, platelets, dendritic cells, and bone marrow-derived macrophages. CD9 has been found to be associated with integrins and other cell-surface receptors, and it is suggested to play a role in signal transduction and possibly in regulating cellular adhesive properties. It has also been demonstrated to participate in T-cell costimulation and induction of apoptosis. The KMC8 antibody has been reported to block certain CD9 functions and activate macrophages
    Pathways
    Response to Water Deprivation, Cell-Cell Junction Organization
Sie sind hier:
Kundenservice